Skip to main content
Hani Hassoun, MD, Hematology, New York, NY

HaniHassounMD

Hematology New York, NY

Associate Professor of Medicine, Cornell University-Weill Medical College

Overview of Dr. Hassoun

Dr. Hani Hassoun is a hematologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Pierre and Marie Curie University and has been in practice 34 years. Dr. Hassoun accepts several types of health insurance, listed below. He is one of 61 doctors at Memorial Sloan Kettering Cancer Center who specialize in Hematology. He also speaks multiple languages, including French. He has more than 100 publications and over 500 citings.

Education & Training

  • St Elizabeth's Medical Center
    St Elizabeth's Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1991
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
  • Pierre and Marie Curie University
    Pierre and Marie Curie University Class of 1983

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2026
  • NJ State Medical License
    NJ State Medical License 2024 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2008-2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
    Hani Hassoun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...
    Hani Hassoun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...
    Hani Hassoun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other Languages

  • French

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment